
- /
- Supported exchanges
- / US
- / PRME.NASDAQ
Prime Medicine, Inc. Common Stock (PRME NASDAQ) stock market data APIs
Prime Medicine, Inc. Common Stock Financial Data Overview
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Prime Medicine, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Prime Medicine, Inc. Common Stock data using free add-ons & libraries
Get Prime Medicine, Inc. Common Stock Fundamental Data
Prime Medicine, Inc. Common Stock Fundamental data includes:
- Net Revenue: 4 961 K
- EBITDA: -197 384 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.43
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Prime Medicine, Inc. Common Stock News

Prime Drink Group Provides Bi-Weekly MCTO Status Report
MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30, August 15, and August 2...


Groupe Prime Drink fournit un rapport bihebdomadaire sur le statut du MCTO
MONTRÉAL, 12 sept. 2025 (GLOBE NEWSWIRE) -- Groupe Prime Drink Corp. (CSE : PRME) (« Prime » ou la « Société ») annonce que, conformément à ses communiqués du 30 juillet, du 15 août et du...

Prime Drink Group Terminates Rights Offering and Announces Private Placement
MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it has terminated its previously disclosed rights offering and that...

Groupe Prime Drink met fin au placement de droits et annonce un placement privé
MONTRÉAL, 04 sept. 2025 (GLOBE NEWSWIRE) -- Groupe Prime Drink Corp. (CSE : PRME) (« Prime » ou la « Société ») annonce qu’elle a mis fin à son placement de droits précédemment divulgu�...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.